TMEM78: A Transmembrane Protein Identified as a Potential Drug Target and Biomarker

Target Name: TMEM78

NCBI ID: G677790

TMEM78

Other Name(s): Transmembrane protein 78 | transmembrane protein 78

TMEM78: A Transmembrane Protein Identified as a Potential Drug Target and Biomarker

TMEM78 (Transmembrane protein 78) is a protein that has been identified as a potential drug target and biomarker. It is a transmembrane protein that is expressed in various tissues and cells, including the brain, pancreas, and gastrointestinal tract. TMEM78 has unique features, such as a long extracellular domain, a short intracellular domain, and a unique N-terminus. These features make it an interesting protein that can be targeted by small molecules.

Drug Target Potential

TMEM78 has been identified as a potential drug target due to its unique structure and various functions. One of its unique features is its long extracellular domain, which contains a portion of a helix that can be involved in protein-protein interactions. This extension can interact with other proteins and molecules, making it a potential target for small molecules. Additionally, TMEM78 has a unique N-terminus that contains a portion of a conserved domain that is known to be involved in protein-protein interactions. This conserved domain can interact with other proteins, which may increase the protein's stability or activity.

TMEM78 has also been shown to play a role in various biological processes, including cell signaling, neurotransmission, and insulin sensitivity. For example, TMEM78 has been shown to interact with the protein PDGF, which is involved in cell signaling. This interaction may contribute to TMEM78's role in cell signaling. Additionally, TMEM78 has been shown to interact with the protein GABA, which is involved in neurotransmission. This interaction may contribute to TMEM78's role in neurotransmission.

Biomarker Potential

TMEM78 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This is due to its unique expression patterns and various functions. For example, TMEM78 is known to be expressed in various tissues and cells, including the brain, pancreas, and gastrointestinal tract. This suggests that it may be a useful biomarker for these diseases. Additionally, TMEM78's unique structure and functions may make it a potential drug target for small molecules. This suggests that it may be a useful target for cancer and neurodegenerative diseases.

Conclusion

In conclusion, TMEM78 is a unique and interesting protein that has been identified as a potential drug target and biomarker. Its long extracellular domain, unique N-terminus, and various functions make it an attractive target for small molecules. Additionally, TMEM78 has been shown to play a role in various biological processes, including cell signaling, neurotransmission, and insulin sensitivity. This suggests that it may be a useful biomarker for various diseases. Further research is needed to determine its potential as a drug target and biomarker.

Protein Name: Transmembrane Protein 78

The "TMEM78 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM78 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets